189 results
Page 5 of 10
8-K
EX-99.1
n4vrhmtj wn
25 May 21
Moleculin Commences Phase 1b/2 Clinical Trial of Annamycin for the Treatment of Sarcoma Lung Metastases
9:01am
8-K
EX-99.1
arf8ex den0es0
14 Apr 21
Moleculin Awarded New Rare Pediatric Disease Designation from U.S. FDA for WP1066 for the Treatment of Ependymoma
7:35am
8-K
EX-99.1
y7q5wf0
6 Apr 21
Moleculin Engages IQVIA to Manage Potential COVID-19 Clinical Trial
7:32am
8-K
EX-99.1
64kzr0c
30 Mar 21
Moleculin Receives FDA Approval of Fast Track
7:30am
8-K
EX-99.1
yl6qkbcmm9hs3 v3pc
24 Mar 21
Moleculin Biotech, Inc. Reports Financial Results
7:31am
8-K
EX-99.1
upp50fs
8 Feb 21
Moleculin Announces Grant Awarded to Polish Research Institute for Independent Clinical Trial of Annamycin in Sarcoma Lung Metastases
7:29am
424B5
8adwz7gqsk
4 Feb 21
Prospectus supplement for primary offering
4:01pm
424B5
kc5bejfz ny
2 Feb 21
Prospectus supplement for primary offering
4:29pm
8-K
EX-99.1
wtnh2x9t9bmhtkq
2 Feb 21
Moleculin Announces 100% Survival Achieved in Osteosarcoma Lung Metastases Animal Model
7:29am
8-K
EX-99.1
tvwge4ux
1 Feb 21
Moleculin Signs Agreement with Catalyst Clinical Research to Begin Sarcoma Trial
7:29am
8-K
EX-99.1
zkqsd32g4a8
29 Dec 20
Moleculin Announces Annamycin Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas
7:29am
8-K
EX-99.1
hj23xgz76anj
17 Dec 20
Moleculin Announces FDA Permission to Begin Clinical Study of Annamycin for Sarcoma Lung Metastases
7:29am
8-K
EX-99.1
6ils0
3 Dec 20
Moleculin To Present Antitumor Activity of Annamycin in Combination with Ara-C in AML at American Society for Hematology Annual Conference
7:29am
8-K
EX-99.1
0pjainpt3 5ca7
19 Nov 20
Moleculin Announces New Data Demonstrating
4:00pm
8-K
EX-99.1
8qvv56obl5oqffelj
13 Nov 20
Moleculin Biotech, Inc. Reports Financial Results
7:29am
424B5
1tdwp
12 Nov 20
Prospectus supplement for primary offering
4:31pm